基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 IPI-549 Eganelisib (IPI-549)
  • aladdin 阿拉丁 E408883 Eganelisib (IPI-549) 1693758-51-8 10mM in DMSO

aladdin 阿拉丁 E408883 Eganelisib (IPI-549) 1693758-51-8 10mM in DMSO

Eganelisib (IPI-549)
1693758-51-8
432.90 5mg 起订
2415.90 25mg 起订
6209.90 100mg 起订
上海 更新日期:2025-05-16

上海阿拉丁生化科技股份有限公司

VIP3年
联系人:阿拉丁客服
电话:400-6206333拨打
手机:13167063860 拨打
邮箱:anhua.mao@aladdin-e.com

产品详情:

中文名称:
Eganelisib (IPI-549)
英文名称:
Eganelisib (IPI-549)
CAS号:
1693758-51-8
品牌:
阿拉丁
产地:
上海
保存条件:
-20°C储存
纯度规格:
Moligand™, ≥97%
产品类别:
小分子和化合物库
分子式:
C30H24N8O2
分子量:
528.56
运输条件:
超低温运输
产品规格:
100mg、25mg、5mg
货号:
E413975
是否进口:

中文名:Eganelisib (IPI-549)

英文名:Eganelisib (IPI-549)

纯度:Moligand™,≥97%

货号:E413975

Cas号:1693758-51-8

存储温度:-20°C储存

运输条件:超低温运输

产品介绍:

Information

Eganelisib (IPI-549) is a potent inhibitor ofPI3K-γwith >100-fold selectivity over other lipid and protein kinases. The biochemicalIC50for PI3K-γ is 16 nM.


Targets

PI3Kγ (Cell-free assay) 16 nM


In vitro

IPI-549 is found to be a remarkably tight binder to PI3K-γ with a Kd of 290 pM and >58-fold weaker affinity for other Class I PI3K isoforms. It does not significantly inhibit a panel of 468 mutant and nonmutant protein and lipid kinases (including Class II PI3K isoforms) at 1 μM. In PI3K-α, -β, -γ, and -δ dependent cellular phospho-AKT assays, IPI-549 demonstrates excellent PI3K-γ potency (IC50 = 1.2 nM) and selectivity against other Class I PI3K isoforms (>146-fold). Furthermore, IPI-549 dose dependently inhibits PI3K-γ-dependent bone marrow-derived macrophage (BMDM) migration in vitro. IPI-549 is also found to be selective against a panel of 80 GPCRs, ion channels, and transporters at 10 μM. IPI-549 shows moderate to high cell permeability across Caco-2 cell monolayers, is slowly metabolized in cultured hepatocytes (t1/2 > 360 min), and demonstrates IC50s greater than 20 μM for the CYP isoforms tested (1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 3A4).


In vivo

In vivo (mice, rats, dog, and monkeys), IPI-549 has excellent oral bioavailability, low clearance, and distributes into tissues with a mean volume of distribution of 1.2 L/kg. It has a favorable pharmacokinetic profile to allow potent and selective inhibition of PI3K-γ in vivo. IPI-549 can significantly reduce neutrophil migration in a dose-dependent manner in mouse model when administered orally at all of the tested doses. In addition, IPI-54 has been shown to inhibit tumor growth in murine syngeneic models through alteration of immune cells in the tumor microenvironment.


Cell Research(from reference)

Cell lines:SKOV-3 cells 

Incubation Time:30 min 


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/E413975.html


伊加尼利西布 (IPI-549);DTXSID301336580 ; NSC801002 ; NSC-801002

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (18年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

Eganelisib (IPI-549)相关厂家报价 更多

  • IPI549
  • IPI549
  • ChemeGen 中国 VIP
  • 2025-11-17
  • ¥820
内容声明
拨打电话 立即询价